Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Therapeutics Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Androgens Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Bone Density Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2011 2018

Research Output 2011 2017

  • 39 Citations
  • 5 h-Index
  • 8 Article
  • 1 Editorial
Medicare Part D
Prostatic Neoplasms
abiraterone
MDV 3100
Prescriptions

The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer

Kirk, P. S., Borza, T., Shahinian, V. B., Caram, M. E. V., Makarov, D. V., Shelton, J. B., Leppert, J. T., Blake, R. M., Davis, J. A., Hollenbeck, B. K., Sales, A. & Skolarus, T. A. Jan 1 2017 (Accepted/In press) In : BJU International.

Research output: Research - peer-reviewArticle

Bone Density
Androgens
Prostatic Neoplasms
Bone and Bones
Health

Treating Advanced Prostate Cancer-the Human Factor

Caram, M. E. V. & Miller, D. C. 2017 (Accepted/In press) In : European Urology.

Research output: Research - peer-reviewArticle

Prostatic Neoplasms
5 Citations
Anthracyclines
Single Nucleotide Polymorphism
Breast Neoplasms
Cardiotoxicity
Doxorubicin

Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis

Caram, M. E. V., Skolarus, T. A. & Cooney, K. A. Aug 1 2016 In : European Urology. 70, 2, p. 209-210 2 p.

Research output: Research - peer-reviewEditorial

Prostate-Specific Antigen
Prostatic Neoplasms
Therapeutics
Guidelines